These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4925903)

  • 1. Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (L1210) mice.
    Vadlamudi S; Padarathsingh M; Bonmassar E; Goldin A
    Int J Cancer; 1971 Jan; 7(1):160-6. PubMed ID: 4925903
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide.
    Skórski T; Kawalec M
    Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
    Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
    Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive immunotherapy of acute leukemia: experimental and clinical results.
    Mathé G; Amiel JL; Schwarzenberg L; Cattan A; Schneider M
    Cancer Res; 1965 Oct; 25(9):1525-31. PubMed ID: 5323965
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of treatment with two related dimethanesulfonates on the life span and spleen and bone marrow cells of leukemic and nonleukemic mice.
    Vadlamudi S; Padarathsingh M; Waravdekar VS; Goldin A
    Chemotherapy; 1971; 16(2):65-75. PubMed ID: 5120610
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
    Vadlamudi S; Waravdekar VS; Choudry JN; Goldin A
    Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
    [No Abstract]   [Full Text] [Related]  

  • 7. Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654).
    Skórski T; Kawalec M
    Bone Marrow Transplant; 1987 Dec; 2(4):435-40. PubMed ID: 3332191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T
    Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemia.
    Mathé G; Halle-Pannenko O; Bourut C
    Eur J Cancer (1965); 1974 Oct; 10(10):661-6. PubMed ID: 4465103
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of antitumor agents on the hematology and transplantability of leukemia L-1210.
    Eckhardt S; Humphreys SR; Goldin A
    Antimicrob Agents Chemother (Bethesda); 1965; 5():503-8. PubMed ID: 5883466
    [No Abstract]   [Full Text] [Related]  

  • 12. Transplantation of leukemic bone marrow treated with cytotoxic antileukemic antibodies and complement.
    Trigg ME; Poplack DG
    Science; 1982 Jul; 217(4556):259-61. PubMed ID: 7046048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of L-1210 leukemia. IV. Ultrastructural findings after in vitro treatment with cyclophosphamide and vitamin A.
    Anton E; Brandes D
    Exp Mol Pathol; 1967 Oct; 7(2):156-81. PubMed ID: 4861338
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient graft-versus-host reaction in the treatment of leukemia in mice.
    Boranić M
    J Natl Cancer Inst; 1968 Aug; 41(2):421-37. PubMed ID: 4876445
    [No Abstract]   [Full Text] [Related]  

  • 15. Allogeneic bone marrow chimerism in germfree mice. 3. Therapy of leukemic AKR mice.
    Truitt RL; Pollard M; Srivastava KK
    Proc Soc Exp Biol Med; 1974 May; 146(1):153-8. PubMed ID: 4597165
    [No Abstract]   [Full Text] [Related]  

  • 16. L1210 leukemia regression in non-immunosuppressed mice with therapeutic transfer of immune spleen cells--therapeutic adoptive transfer against L1210 leukemia.
    Kawashima K; Nagura E; Nagase F; Kumazawa T; Nakashima I; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1987 Sep; 50(6):1174-82. PubMed ID: 3687342
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental study of the antileukemic effect of Endoxan in combination with bone marrow cell and spleen cell transplantation].
    Bergol'ts VM; Sukhin GM
    Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):36-9. PubMed ID: 4900638
    [No Abstract]   [Full Text] [Related]  

  • 18. [Trial treatment of leukemia L 1210 by allogenic hematopoietic graft according to the cell type of the graft].
    Crochet MF; Florentin I; Martyre MC; Rosenkovitch E
    Rev Fr Etud Clin Biol; 1965 Dec; 10(10):1074-6. PubMed ID: 5323452
    [No Abstract]   [Full Text] [Related]  

  • 19. The elimination of leukemic cells from autologous marrow by hyperthermia.
    Symonds RP; Wheldon TE
    Int J Radiat Oncol Biol Phys; 1982 Nov; 8(11):2033-34. PubMed ID: 6759488
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice.
    Vadlamudi S; Choudry JN; Waravdekar VS; Kline I; Goldin A
    Cancer Res; 1970 Feb; 30(2):362-9. PubMed ID: 5458970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.